OMEPRAZOLE EXTENDED
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded Contract SPE2DP26F3566 to DMS PHARMACEUTICAL GROUP INC with a CAGE code of 1UNB0 for the supply of OMEPRAZOLE EXTENDED, identified by NSN 6505016247068. This award, dated July 21, 2026, is issued under the parent contract SPE2DX25D9900 and represents a delivery order for a critical pharmaceutical item within the Department of Defense’s medical supply chain. The total contract value is specified in the award documentation, though not disclosed publicly here, and the award is classified as a federal transaction with no set-aside provisions indicated. Performance location details are not provided, but the contract is managed under the DLA’s procurement framework and is accessible via the DIBBS portal. The award reflects ongoing logistical support for military medical needs, with DMS PHARMACEUTICAL GROUP INC designated as the sole provider for this extended-release formulation.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
